MAETZOLD DEREK J sold $711K of CSTL
MAETZOLD DEREK J (Pres. & Chief Exec. Officer) sold 22,902 shares of CASTLE BIOSCIENCES INC (CSTL) at an average of $31.06 ($30.68–$31.34, $0.71M total) across 3 trades over 2026-08-04 to 2026-08-05 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The CEO executed an open-market sale of 22,902 shares at a weighted average price of $31.0617, totaling $711,374.74, with holdings after the transaction of 21,479 shares.
Market read
Traders may monitor for follow-on insider activity, but the disclosure itself is not a fundamental catalyst.
What to watch
The filing does not disclose reasons for the sale, and the net impact depends on whether there are additional insider transactions around the same period.
Background
The article is an SEC Form 4 insider transaction disclosure for CASTLE BIOSCIENCES INC (CSTL).
Ticker impact
CSTL CEO Maetzold sold $711K of shares via an open-market sale under a pre-arranged 10b5-1 plan, reducing direct holdings to 21,479 shares.
Low likelihood of a sustained price move; any reaction is likely limited to short-term sentiment around insider selling.
The filing is a Form 4 insider transaction, explicitly tied to a pre-arranged 10b5-1 plan, and provides no new company fundamentals beyond the sale details.
Market effects
No sector read-through is provided; this appears company-specific and plan-driven.
None indicated.
None indicated.
Counterpoint
Because the sale is under a pre-arranged 10b5-1 plan, it may reflect scheduled liquidity needs rather than bearish expectations.
Key entities
- issuerCASTLE BIOSCIENCES INC
Subject of the Form 4 insider transaction disclosure.
- insiderMAETZOLD DEREK J
President and Chief Executive Officer who sold shares under a 10b5-1 plan.
